This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sonomed Escalon™ Announces Integration Of AXIS™ Image Management With MaximEyes EHR

Stocks in this article: ESMC

WAYNE, Pa., June 24, 2013 /PRNewswire/ -- Escalon® Medical Corp. (Nasdaq: ESMC) today announced its Sonomed Escalon™ group has completed deep integration of its AXIS™ Image Management platform with MaximEyes EHR ophthalmic electronic health records system provided by First Insight® Corporation. The integration enables users to directly access all patient diagnostic images from directly within MaximEyes EHR.

"While AXIS can interface with any EHR system, the deep integration with MaximEyes provides a greater convenience and saves users time," said Matthew Carnevale, Sonomed Escalon's Chief Technology Officer. "MaximEyes EHR is a leading EHR provider for ophthalmology and this integration further enhances the value proposition of a combined solution."

"Partnering with Sonomed Escalon continues our commitment to expand MaximEyes EHR functionalities with certified partner integrations and to help practices simplify managing their patient data," said Nitin Rai, President and CEO of First Insight® Corporation. "This built-in integration allows MaximEyes EHR users to quickly connect to the Sonomed Escalon AXIS image management system, and display exam records and diagnostic images for a specific patient. In addition, MaximEyes users can host this integration locally or in a cloud environment."

About Escalon Medical:  Founded in 1987, Escalon Medical Corp. ( www.escalonmed.com) develops markets and distributes ophthalmic diagnostic and surgical products. The Company seeks to further develop and diversify its product offering through internal development programs, strategic partnerships, and acquisition of technology so as to best leverage the Company's distribution capabilities, although such development, partnerships or acquisitions may or may not occur. The Company has headquarters in Wayne, Pennsylvania and operations in Lake Success, New York, New Berlin, Wisconsin and Stoneham, Massachusetts.

About First Insight Corporation: First Insight was founded in 1994 by Nitin Rai, president and CEO, to revolutionize and lead the eye care industry with the most complete and customizable certified electronic health records and practice management software. The company's focus has been to help doctors achieve a paperless practice through MaximEyes, its flagship "eye care only" Cloud-based EHR and practice management software. MaximEyes helps thousands of eye care professionals increase revenue, reduce billing errors, improve patient retention, enhance office efficiency, and relieve the stress of regulatory requirements. The company provides award winning training and development to make implementation simple.  First Insight is headquartered in Hillsboro, OR. To learn more, visit www.first-insight.com.

Note: This press release contains statements that are considered forward-looking under the Private Securities Litigation Reform Act of 1995, including statements about the Company's future prospects. These statements are based on the Company's current expectations and are subject to a number of uncertainties and risks, and actual results may differ materially. The uncertainties and risks include whether the Company is able to:

  • implement its growth and marketing strategies, improve upon the operations of the Company business units, including the ability to make acquisitions and the integration of any acquisitions it may undertake, if any, of which there can be no assurance,
  • grow our remaining ophthalmic business unit,
  • implement cost reductions,
  • generate cash,
  • identify, finance and enter into business relationships and acquisitions.

Other factors include uncertainties and risks related to:

  • new product development, commercialization, manufacturing and market acceptance of new products,
  • marketing acceptance of existing products in new markets,
  • research and development activities, including failure to demonstrate clinical efficacy,
  • delays by regulatory authorities, scientific and technical advances by the Company or third parties,
  • introduction of competitive products,
  • ability to reduce staffing and other costs and retain benefit of prior reductions,
  • third party reimbursement and physician training, and
  • general economic conditions.

Further information about these and other relevant risks and uncertainties may be found in the Company's report on Form 10- K for year ended June 30, 2012, and its other filings with the Securities and Exchange Commission, all of which are available from the Securities and Exchange Commission as well as other sources.

SOURCE Escalon Medical Corp.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,411.88 +12.21 0.07%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs